{"id":35873,"date":"2024-03-23T16:55:43","date_gmt":"2024-03-23T16:55:43","guid":{"rendered":"https:\/\/medgyd.lt\/cc\/exelon-95-mg-24-val-transderminis-pleistras-n7-popierius-pet-alu-pan-19216\/"},"modified":"2024-03-23T16:55:44","modified_gmt":"2024-03-23T16:55:44","slug":"exelon-95-mg-24-val-transderminis-pleistras-n7-popierius-pet-alu-pan-19216","status":"publish","type":"post","link":"https:\/\/medgyd.lt\/cc\/exelon-95-mg-24-val-transderminis-pleistras-n7-popierius-pet-alu-pan-19216\/","title":{"rendered":"Exelon 9,5 mg\/24 val transderminis pleistras N7 (popierius\/PET\/alu\/PAN)"},"content":{"rendered":"<h1>Detali informacija apie Exelon 9,5 mg\/24 val<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Veiklioji med\u017eiaga:<\/strong> Rivastigminas<\/p>\n<p><strong>Veikliosios med\u017eiagos koncentracija:<\/strong> 9,5 mg\/24 val<\/p>\n<p><strong>Vartojimo b\u016bdas:<\/strong> vartoti ant odos<\/p>\n<p><strong>Vaistinio preparato grup\u0117:<\/strong> Vaistinis preparatas<\/p>\n<p><strong>Kitos vaisto dozuot\u0117s: <\/strong>N7 (popierius\/PET\/alu\/PAN), N30 (popierius\/PET\/alu\/PAN), N60 (2&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N90 (3&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N42 (popierius\/PET\/alu\/PAN), N84 (2&#215;42) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N7 (popierius\/PET\/PE\/alu\/PA), N30 (popierius\/PET\/PE\/alu\/PA), N60 (2&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA), N90 (3&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA), N42 (popierius\/PET\/PE\/alu\/PA), N84 (2&#215;42) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA)<strong><br \/>\n<\/strong><\/p>\n<p><strong>Vaistinio preparato pogrupis:<\/strong> Cheminis<\/p>\n<p><strong>Recepto poreikis:<\/strong> Receptinis<\/p>\n<p><strong>Preparato ATC kodas:<\/strong> N06DA03<\/p>\n<p><strong>Pakuot\u0117s tipas:<\/strong> paket\u0117lis<\/p>\n<p><strong>Dozuot\u0117 pakuot\u0117je:<\/strong> N7 (popierius\/PET\/alu\/PAN)<\/p>\n<p><strong>Vaisto stadija:<\/strong> Registruotas 2007-09-17 EU\/1\/98\/066\/023<\/p>\n<p><strong>Registruotojas: <\/strong>Novartis Europharm Ltd..<\/p>\n<p><strong>Perregistravimo data: <\/strong><\/p>\n<p><strong>Registracijos \u0161alis: <\/strong>Airija<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Exelon sud\u0117tyje yra: Rivastigminas &#8211; 9,5 mg\/24 val transderminis pleistras. Preparatas skirtas vartoti vartoti ant odos. Receptinis preparatas. Pakuot\u0119 sudaro N7 (popierius\/PET\/alu\/PAN), N30 (popierius\/PET\/alu\/PAN), N60 (2&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N90 (3&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N42 (popierius\/PET\/alu\/PAN), N84 (2&#215;42) (sud\u0117tin\u0117) (popierius\/PET\/alu\/PAN), N7 (popierius\/PET\/PE\/alu\/PA), N30 (popierius\/PET\/PE\/alu\/PA), N60 (2&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA), N90 (3&#215;30) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA), N42 (popierius\/PET\/PE\/alu\/PA), N84 (2&#215;42) (sud\u0117tin\u0117) (popierius\/PET\/PE\/alu\/PA) paket\u0117lis<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,1502,8825,4,5],"tags":[120,1504,119,1505,2488],"class_list":["post-35873","post","type-post","status-publish","format-standard","hentry","category-cheminis","category-exelon","category-exelon-95-mg-24-val","category-vaistai","category-vaistinis-preparatas-vaistai","tag-cheminis","tag-exelon","tag-receptinis","tag-rivastigminas","tag-transderminis-pleistras"],"_links":{"self":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/35873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/comments?post=35873"}],"version-history":[{"count":1,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/35873\/revisions"}],"predecessor-version":[{"id":48998,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/35873\/revisions\/48998"}],"wp:attachment":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/media?parent=35873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/categories?post=35873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/tags?post=35873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}